Source comparison
BPC-157 for Tennis Elbow: Type Comparison
BPC-157 Systemic Upregulates VEGF, enhances collagen synthesis, supports angiogenesis throughout the body Subcutaneous injection (abdomen, thigh) 250 mcg daily 2–4 weeks for measurable tendon changes Best for researchers exploring broad regenerative effects; a
This comparison does not assign a generated winner or score.
- BPC-157 Systemic
- Upregulates VEGF, enhances collagen synthesis, supports angiogenesis throughout the body
- Subcutaneous injection (abdomen, thigh) 250 mcg daily
- 2–4 weeks for measurable tendon changes
- Best for researchers exploring broad regenerative effects; avoids direct tendon trauma
- BPC-157 Local Injection
- Same mechanism, concentrated at injury site via peri-tendinous delivery
- Ultrasound-guided injection near lateral epicondyle, 200–300 mcg 2–3× weekly
- 1–3 weeks for localized effect
- Highest theoretical bioavailability at tendon-bone interface; requires trained clinician
- Eccentric Exercise Protocol
- Mechanotransduction stimulates organized collagen remodeling under controlled load
- Wrist extension exercises with resistance, 3 sets × 15 reps daily
- 6–12 weeks for symptomatic improvement
- Gold standard physical therapy; works but requires months of consistent execution
- PRP (Platelet-Rich Plasma)
- Growth factor delivery (PDGF, TGF-β) from autologous platelets
- Single injection into tendon-bone interface, ultrasound-guided
- 4–8 weeks for noticeable effect
- More expensive, requires blood draw and centrifugation; evidence base stronger than BPC-157
- Corticosteroid Injection
- Suppresses inflammation and pain signaling via glucocorticoid receptor activation
- Single injection into tendon sheath (not tendon itself)
- Immediate pain relief, lasts 6–12 weeks
- Does not promote healing; may weaken tendon structure long-term; symptom management only